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Discussion: This study demonstrates clear effects of TGFI~ on 
collagen network. These effects are different from the effects of 
TGFI~ on fibroblasts. The consequences of these findings for the 
quality of the matrix engineered by chondrocytes are under cur- 
rent investigation. 
P317 
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C Sanchez, E Kaut, MA Deberg, YE Henrotin 
Bone and Cartilage Research Unit, University of Liege, Liege, 
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Aim of Study: Previously, we have demonstrated that os- 
teoblasts from the sclerotic subchondral bone express a partic- 
ular phenotype characterized by an overproduction of interleukin 
(I L)-6, transforming rowth factor (TGF)-I~I, alkaline phosphatase 
and osteocalcin but similar amount of IL-11~ than non sclerotic os- 
teoblasts. Further, we have observed in a co-culture model that 
osteoblasts from the sclerotic zone of osteoarthritic (OA) sub- 
chondral bone affected the metabolism of chondrocytes and their 
production of aggrecan, sox9 and MMPs. This work was designed 
to identify the mediators involved in these osteoblasts-induced ef- 
fects. 
Methods: Human chondrocytes were isolated from OA cartilage 
and cultured in alginate beads for 4 days in the absence or in 
the presence of non sclerotic or sclerotic OA subchondral os- 
teoblasts in monolayer (co-culture system). During co-culture, 
monoclonal antibodies (Mab) neutralizing IL-6, TGF-I~1-3 or hep- 
atocyte growth factor (HGF) were added. Chondrocytes in mono- 
culture and chondrocytes/fibroblasts co-culture were conducted 
in parallel as controls. Aggrecan, sox9 and matrix metallopro- 
teases (MMP) -3 and -13 mRNA levels in chondrocytes were 
quantified by real time polymerase chain reaction. Aggrecan and 
MMP-3 production was assayed by a specific enzyme amplified 
sensitivity immunoassay (EASIA). 
Results: In co-culture, sclerotic, but not non sclerotic, osteoblasts 
significantly decreased (- 27%, p<0.001) aggrecan production 
and aggrecan gene expression by human chondrocytes. In paral- 
lel, sox9 expression was decreased (- 52%, p < 0.001) whereas 
MMP-3 and MMP-13 gene expression were increased (+ 44 and 
+ 76%, respectively, p < 0.001). Anti-lL-6 Mab prevents all these 
osteoblasts-induced effects. 
Conclusions: OA subchondral osteoblasts could contribute to 
cartilage degradation by stimulating chondrocytes to produce 
more matrix metalloproteases and by inhibiting aggrecan syn- 
thesis. Herein, we have identified IL-6 as a key mediator of the 
osteochondral pathophysiological xis. To neutralize IL-6 biolog- 
ical activity prevents the negative effects of sclerotic osteoblasts 
on cartilage metabolism. 
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Aim of the study: The objective of this study was to compare 
the effects of 500-730 kDa Hyaluronic acid (HA) and the amide 
derivative hyaluronic acid (HYADD4-G), with higher viscoelastic- 
ity properties, on in vitro human chondrocyte and synoviocite cul- 
tures. 
Materials: - Human chondrocytes isolated from pathological ar- 
ticular cartilage biopsies by enzymatic digestion and expanded in 
monolayer to the second culture passage with complete Ham's 
F12 medium. 
- Human synoviocytes isolated from the synovial tissue of pa- 
tients undergoing surgery for ligament repair. 
Methods: - Cells were grown in culture with or without HA or 
HYADD4-G at different concentrations (0,5 and 1,5 mg/ml) for 3- 
6-9 days. 
- The mediation of HA effects by the CD44 receptor was tested 
by receptor binding inhibition using a mouse anti-human CD44 
monoclonal antibody at saturating concentrations. 
- Viability of cells was determined using the MTT-based cytotoxi- 
city test. 
- The differences between cell viability data obtained with the dif- 
ferent concentrations of HA and its amide derivative, were anal- 
ysed by the ANOVA test. 
Results: Synoviocyte viability: In in vitro synoviocyte cultures, af- 
ter 9 days, the presence of, HA or its amide derivative at the con- 
centration of 0.5 mg/ml, does not significantly increases cell via- 
bility. When added at the concentration of 1,5 mg/ml for 3, 6 or 
9 days in culture, native HA slightly inhibits synoviocyte growth, 
whereas the same quantity of the amide derivative of HA, strongly 
inhibits viability of cells. 
Chondrocyte viability: The addition of HA or HYADD4-G in- 
creases significantly normal chondrocyte growth both at 0,5 and 
at 1,5 mg/ml concentrations. 
Influence of the binding CD44/HA on cell proliferation: In the pres- 
ence of maximum competitive binding of the CD44 receptor, no 
increased cell viability in chondrocytes cultured with HA and its 
amide derivative is observed. On the contrary the inhibition of 
synoviocyte proliferation with HA or HYADD4-G at the concentra- 
tion of 1,5 mg/ml is not modified by the presence of antiCD44 
Furthermore, the addition of anti CD44 antibodies to control cells 
in the absence of exogenous HA at 9 days, significantly inhibited 
the normal growth in both cell populations. 
Conclusions: Our study demonstrated that HA and its amide 
derivative, similarly influence cell viability even if the rheological 
properties are different. HA and HYADD4-G positively influence 
chondrocyte proliferation while no increase is observed in syn- 
oviocytes. The proliferative ffect is due to the binding of HA to 
its cellular receptor CD44. While chondrocyte growth is positively 
sensitive also to higher concentrations of HA, at the same con- 
centrations synoviocyte proliferation is inhibited. This inhibition 
is higher in the presence of the amide derivative HA and is in- 
dependent from the binding CD44-HA, suggesting that synovio- 
cytes could be more sensitive than chondrocytes to the changes 
in Hyaluronic acid concentration, rheological properties or config- 
uration. 
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Aim of study: Prostaglandin E2 (PGE2) exerts its actions 
through the binding of the high affinity EP receptors. In humans, 
there are 4 subtypes of EP receptors that can be divided in Ca 2 + 
mobilizing receptors and cAMP mobilizing receptors. EP sub- 
types density in cells or tissues is therefore central to understand 
the pathways elicited by PGE2. We wanted to evaluate the reg- 
ulation of EP1 (a Ca 2 + mobilizing receptor) and EP4 (a cAMP 
mobilizing receptor), and the expression of COX-2, the main en- 
zyme responsible for PGE2 synthesis in inflammatory situations, 
$158 Poster  P resentat ions  
in healthy rabbit chondrocytes timulated with inflammatory me- 
diators that are locally increased during osteoarthritis. 
Methods: Articular chondrocytes (AC) were obtained from the 
femur and tibia of healthy rabbits and cultured in DMEM. Qui- 
escent cells were stimulated with interleukin-1 (IL-1) I~ or tumor 
necrosis factor (TNF) ~. Where indicated, cells were preincubated 
with PGE2 synthesis inhibitors, such as meloxicam (MXC) or di- 
clofenac (DCF) for 60 min. NSAIDs were maintained uring the 
whole period of incubation. Total RNA was extracted from AC, 
and gene expression was studied by RT-PCR techniques. 
Results: IL-11~ induced a dose and time dependent increase in 
the gene expression of both EP1 and EP4 receptors, with a peak 
at 18 h of incubation (10 U/mL IL-I: EP1,7.24-1.3; EP4, 16.84-3.2 
fold vs. basal). However, TNF~ presence (5 to 100 ng/mL) did 
not induce a statistically significant modification of EP1 or EP4 
gene expression at any time studied (0 to 24 h of incubation). 
We also studied if PGE2 could play a role on the expression of 
EP receptors induced by IL-11~. Firstly, we studied COX-2 mRNA 
expression in AC incubated with IL-11~ or TNF~. IL-11~ induced a 
dose and time dependent increase in COX-2 expression in AC 
with a peak at 24 h of incubation (206 fold vs basal). TNF~ did 
not modify COX-2 expression at any time studied. AC were then 
preincubated with MXC or DCF in order to inhibit endogenous 
PGE2 synthesis in response to IL-1 I~ incubation. NSAID presence 
did not significantly modify EP1 or EP4 gene expression induced 
by IL-11~. 
Conclusions: Our results indicate that EP1 and EP4 PGE2 
receptors, and COX-2 are up-regulated in IL-11~-stimulated 
AC, while no significant modifications are observed in TNF~- 
stimulated cells. NSAIDs were unable to modify the expression 
of these mediators induced by IL-11~. Therefore, the increase in 
PGE2 synthesis induced by IL-11~ does not seem to mediate the 
increase in EP receptor expression in AC. 
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UPREGULATION OF GLUCOSE TRANSPORT IN 
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EQUINE JOINTS: MODULATORY EFFECTS OF 
MELOXICAM 
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Introduction: Osteoarthritis (OA) is one of the most common 
causes of lameness in the horse. It is generally accepted that 
metabolic energy is required to initiate and sustain inflammation 
which is a closely integrated process in the progression of OA. 
Chondrocytes are highly metabolic and glycolytic cells that me- 
tabolize glucose as a primary substrate for ATP production. We 
and others have shown that glucose uptake into chondrocytes 
is a facilitative process that is accelerated by pro-inflammatory 
cytokines and is mediated by several facilitative hypoxia and 
cytokine-responsive glucose transporter (GLUT) isoforms. 
Aim of Study: We hypothesized that chondrocytes isolated 
from OA joints would exhibit increased glucose transport com- 
pared to chondrocytes from normal joints. In this study we mea- 
sured the specific uptake of non-metabolizable 2-deoxy-D-[2,6- 
3H] glucose into normal, cytokine stimulated and OA chondro- 
cytes and assessed the effects of meloxicam, a non-steroidal 
anti-inflammatory drug and preferential COX-2 inhibitor, on glu- 
cose uptake in normal and cytokine stimulated cells. 
Methods: Equine chondrocytes were isolated from normal and 
OA joints by collagenase digestion and grown in monolayer cul- 
ture with 4% fetal calf serum for no more than two passages. The 
uptake of 2-deoxyglucose into normal and OA chondrocytes from 
equine joints was compared with C20/A4 human chondrocyte- 
like cells. Glucose uptake experiments were also performed with 
equine chondrocytes timulated for 48 h with human recombinant 
tumor necrosis factor ~ (TNF-~, 10 ng/ml), human recombinant in- 
terleukin 11~ (IL-11~, 10 ng/ml), human recombinant oncostatin M 
(OSM, 10 ng/ml) 4- meloxicam (5 i~g/ml - physiological concen- 
tration). 
Results: The rate of glucose transport into chondrocytes isolated 
from OA joints was significantly higher than cells derived from 
normal joints and human C20/A4 chondrocyte-like cells (Fig. 1A). 
The pro-inflammatory c tokines TNF-~ and IL-1 I~ significantly in- 
creased bulk glucose uptake in equine articular chondrocytes 
(up to 325% and 318% respectively) but no alteration in glu- 
cose transport was seen with human recombinant OSM (Fig. 1 B). 
Treatment with meloxicam resulted in a modest decrease in glu- 
cose transport in TNF-~ and IL-11~ stimulated chondrocytes but 
no effect was seen with control and OSM treated cells (Fig. 1 B). 
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Conclusions: This study demonstrates that TNF-~ and IL-11~ 
stimulated chondrocytes and cells derived from OA joints trans- 
port increased quantities of glucose compared with OSM treated 
cells and cells from normal joints. The meloxicam data suggest 
that this drug also has the capacity to reduce glucose transport 
which is needed to sustain inflammation i  OA. 
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Aims: To elucidate the role of NO on the regulation of NF-KB 
activation in human osteoarthritic (OA) chondrocytes. 
Methods: Human condrocytes were isolated from the cartilage 
of the femoral condyles obtained from 13 OA patients undergoing 
